Literature DB >> 10840254

Beliefs about voices and their effects on coping strategies.

J Sayer1, S Ritter, K Gournay.   

Abstract

Cognitive behavioural techniques are increasingly used as adjuncts to medication in the treatment of auditory hallucinations for people with schizophrenia. There are now literally hundreds of nurses trained in the use of cognitive behavioural interventions for psychosis. However, there is still disagreement about the nature of the cognitive processes that lead to deficits or biases in patients' processing of information about their psychotic experiences. Using Chadwick & Birchwood's Beliefs About Voices Questionnaire (BAVQ), the investigator collected data regarding voices from a sample of men and women being treated for schizophrenia by secondary mental health services. The investigator then carried out a cross-lagged panel analysis of the data. The investigator found, as predicted, positive relationships between a resistive coping style and an attribution of malevolence to voices, and between an engaging coping style and an attribution of benevolence to voices. Coping and attributional styles were not necessarily stable over time. There was a non-significant difference between women's and men's attributions and coping styles. There was less fluctuation over time in the women's scores on the BAVQ. This research shows that one cannot assume that either coping or attributional style becomes more stable over time. However, while there are strong relationships between attributions and coping styles, and particularly between malevolence and resistance and benevolence and engagement, these relationships are not necessarily mutually exclusive and some people in the study believe their voices to be both malevolent and benevolent. These findings suggest that clinicians need to make a very careful assessment of attribution and coping with regard to hallucinations and that systematic reassessment is very important. Further research is necessary in both the phenomenology of attribution and coping, but also to relate these variables to other aspects of schizophrenic illnesses.

Entities:  

Mesh:

Year:  2000        PMID: 10840254     DOI: 10.1046/j.1365-2648.2000.01375.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  6 in total

Review 1.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  Overgeneral autobiographical memory bias in clinical and non-clinical voice hearers.

Authors:  Pamela Jacobsen; Emmanuelle Peters; Thomas Ward; Philippa A Garety; Mike Jackson; Paul Chadwick
Journal:  Psychol Med       Date:  2018-03-14       Impact factor: 7.723

3.  "Sometimes I walk and walk, hoping to get some peace." Dealing with hearing voices and sounds nobody else hears.

Authors:  Anne Martha Kalhovde; Ingunn Elstad; Anne-Grethe Talseth
Journal:  Int J Qual Stud Health Well-being       Date:  2014-03-26

4.  Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patients.

Authors:  Helene Hjelmervik; Alexander R Craven; Erik Johnsen; Kristiina Kompus; Josef J Bless; Igne Sinkeviciute; Rune A Kroken; Else-Marie Løberg; Lars Ersland; Renate Grüner; Iris E Sommer; Kenneth Hugdahl
Journal:  Brain Behav       Date:  2021-12-07       Impact factor: 2.708

5.  Voices to reckon with: perceptions of voice identity in clinical and non-clinical voice hearers.

Authors:  Johanna C Badcock; Saruchi Chhabra
Journal:  Front Hum Neurosci       Date:  2013-04-03       Impact factor: 3.169

6.  "Figuring out how to be normal": Exploring how young people and parents make sense of voice-hearing in the family context.

Authors:  Claire Mayer; Guy Dodgson; Angela Woods; Ben Alderson-Day
Journal:  Psychol Psychother       Date:  2022-01-20       Impact factor: 3.966

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.